GAMMA Investing LLC Increases Position in Axon Enterprise, Inc. (NASDAQ:AXON)

GAMMA Investing LLC grew its position in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 58,725.5% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 764,731 shares of the biotechnology company's stock after buying an additional 763,431 shares during the period. GAMMA Investing LLC owned approximately 1.00% of Axon Enterprise worth $402,210,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in AXON. MassMutual Private Wealth & Trust FSB increased its position in shares of Axon Enterprise by 33.6% during the first quarter. MassMutual Private Wealth & Trust FSB now owns 350 shares of the biotechnology company's stock valued at $184,000 after acquiring an additional 88 shares in the last quarter. 111 Capital purchased a new position in shares of Axon Enterprise in the fourth quarter worth $280,000. Wealth Enhancement Advisory Services LLC raised its stake in shares of Axon Enterprise by 36.3% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 16,932 shares of the biotechnology company's stock worth $10,063,000 after purchasing an additional 4,510 shares during the last quarter. Lansforsakringar Fondforvaltning AB publ purchased a new position in shares of Axon Enterprise in the fourth quarter worth $13,986,000. Finally, Centaurus Financial Inc. raised its stake in shares of Axon Enterprise by 43.9% in the fourth quarter. Centaurus Financial Inc. now owns 6,517 shares of the biotechnology company's stock worth $3,873,000 after purchasing an additional 1,989 shares during the last quarter. Institutional investors own 79.08% of the company's stock.

Insider Activity

In other news, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction that occurred on Monday, April 21st. The shares were sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the transaction, the chief executive officer now directly owns 3,063,982 shares in the company, valued at approximately $1,657,583,622.18. This trade represents a 0.33% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Jeri Williams sold 307 shares of Axon Enterprise stock in a transaction on Monday, March 17th. The shares were sold at an average price of $552.72, for a total value of $169,685.04. Following the completion of the transaction, the director now owns 1,627 shares in the company, valued at $899,275.44. This represents a 15.87% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 34,969 shares of company stock worth $23,127,314. Company insiders own 4.40% of the company's stock.

Analysts Set New Price Targets

Several research analysts have recently weighed in on AXON shares. JMP Securities restated an "outperform" rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. Needham & Company LLC boosted their price target on Axon Enterprise from $600.00 to $750.00 and gave the stock a "buy" rating in a research note on Thursday, May 8th. Barclays boosted their price target on Axon Enterprise from $726.00 to $735.00 and gave the stock an "overweight" rating in a research note on Friday, May 9th. Northcoast Research cut Axon Enterprise from a "buy" rating to a "neutral" rating in a research report on Wednesday, February 19th. Finally, Craig Hallum cut Axon Enterprise from a "buy" rating to a "cautious" rating in a research report on Monday, March 10th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and ten have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $652.73.

Axon Enterprise Trading Up 1.1%

Shares of AXON stock traded up $8.21 on Monday, reaching $758.57. 520,984 shares of the company's stock were exchanged, compared to its average volume of 738,736. Axon Enterprise, Inc. has a 52 week low of $273.52 and a 52 week high of $765.00. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $59.06 billion, a PE ratio of 196.01, a P/E/G ratio of 5.17 and a beta of 1.24. The company's fifty day simple moving average is $620.57 and its 200 day simple moving average is $610.60.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 EPS for the quarter, topping analysts' consensus estimates of $1.34 by $0.07. The business had revenue of $603.63 million for the quarter, compared to the consensus estimate of $585.67 million. Axon Enterprise had a net margin of 15.37% and a return on equity of 7.50%. The company's revenue for the quarter was up 31.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.15 EPS. As a group, analysts forecast that Axon Enterprise, Inc. will post 5.8 EPS for the current year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.